MPD: Phenotype measures mapped to VT:0005369, muscular system trait

Phenotype measures directly associated with ontology term
VT:0005369 'muscular system trait'

This list only includes measures mapped to VT:0005369 directly. Measures mapped to its ontology descendants are not included. Alternatively, you can show measures mapped to VT:0005369 AND its descendants.

VT:0003081 soleus morphology trait
VT:0003082 gastrocnemius morphology trait
VT:0003083 tibialis anterior morphology trait
VT:0003084 skeletal muscle fiber morphology trait
VT:0003398 skeletal muscle size trait
VT:0004142 muscle tone
VT:0004246 extensor digitorum longus morphology trait
VT:0010080 skeletal muscle physiology trait
VT:0010119 skeletal muscle cellular composition trait
VT:0010569 quadriceps morphology trait
VT:0010648 muscle glycogen amount
VT:1000429 muscle lactate amount
VT:1000712 skeletal muscle mass
VT:1000747 type I muscle fiber quantity
VT:1000748 type IIa muscle fiber quantity

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Auwerx1:221	Auwerx1	organ weights	high-fat diet	skeletal muscle weight [g] muscle_wt 111400 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:233	Auwerx1	organ weights	high-fat diet	soleus muscle weight [g] soleus_wt 111412 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Brockmann1:8	Brockmann1	muscle weights	(none)	muscle weight [mg] Mw 21308	QTL population		both	6wks	N=138	2009

Brockmann1:25	Brockmann1	muscle weights	(none)	muscle weight [mg] mw 21505	QTL population		both	6wks	N=201	2009

Churchill1:9	Churchill1	muscle weights	(none)	weight of isolated quadriceps muscle [g] quadricep_wt 17109	F1 8way	63	both	7-8wks	N=5	2004

Crabbe4:6	Crabbe4	grip strength	ethanol	grip strength test: peak force applied [g] grip 19106 baseline 30min after ethanol	inbred	21	both	7-12wks	N=6	2003

Crabbe4:8	Crabbe4	grip strength	ethanol	change in peak force applied (T0-T30) post-injection, grip strength test [g] gripEtOHeffect 19108	inbred	21	both	7-12wks	N=6	2003

Crabbe4:9	Crabbe4	grip strength	ethanol	percent change in average latency to fall post-injection, grip strength test [%] pct_gripchange 19109	inbred	21	both	7-12wks	N=6	2003

Donahue2:22	Donahue2	DXA	(none)	cross-sectional area of thigh muscle and bone, femoral mid-diaphysis [mm²] thigh_area 17222	inbred	10	both	16wks	N=10	2004

Donahue2:23	Donahue2	DXA	(none)	cross-sectional thigh muscle area (thigh area minus femur area), femoral mid-diaphysis [mm²] thigh_muscle_area 17223	inbred	10	both	16wks	N=10	2004

Donahue2:24	Donahue2	muscle weights	(none)	weight of isolated right quadriceps muscle [g] quadricep_wt 17224	inbred	10	both	16wks	N=10	2004

GMC02:11	GMC02	grip strength	(none)	forelimb grip strength [g] front_paws 55111 trial1 trial2 trial3	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:14	GMC02	grip strength	(none)	forelimb grip strength, mean [g] front_paws_mean 55114	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:15	GMC02	grip strength	(none)	forelimb grip strength (mean) normalized to body weight [ratio] front_paws_adj 55115	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:21	GMC02	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws 55121 trial1 trial2 trial3	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:24	GMC02	grip strength	(none)	forelimb and hindlimb grip strength, mean [g] all_paws_mean 55124	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:25	GMC02	grip strength	(none)	forelimb and hindlimb grip strength (mean) normalized to body weight [ratio] all_paws_adj 55125	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:44	GMC03	observation (SHIRPA)	(none)	gait (0=fluid, 1=abnormal) [score] gait 55244	inbred w/CC8	8	both	8-10wks	N=17	2018

JaxCC1:9096	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws 89096 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9099	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws_summ 89099 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxCC1:9106	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws 89106 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9109	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws_summ 89109 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxKOMP-EAP:35	JaxKOMP-EAP	grip strength	(none)	forelimb grip strength by trial [g] front_paws forelimb_strength 100561 trial1 trial2 trial3	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:38	JaxKOMP-EAP	grip strength	(none)	forelimb and hindlimb grip strength by trial [g] all_paws forehind_limb_strength 100564 trial1 trial2 trial3	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:42	JaxKOMP-EAP	grip strength	(none)	forelimb grip strength (mean of trials) [g] front_paws_mean forelimb_grip_mean 100571 average average normalized to bw	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:44	JaxKOMP-EAP	grip strength	(none)	forelimb and hindlimb grip strength (mean of trials) [g] all_paws_mean fore_and_hind_limb_grip_mean 100572 average average normalized to bw	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-LAP:131	JaxKOMP-LAP	grip strength	(none)	forelimb grip strength by trial [g] front_paws forelimb_strength 101561 trial1 trial2 trial3	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:134	JaxKOMP-LAP	grip strength	(none)	forelimb and hindlimb grip strength by trial [g] all_paws forehind_limb_strength 101564 trial1 trial2 trial3	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:138	JaxKOMP-LAP	grip strength	(none)	forelimb grip strength (mean of trials) [g] font_paws_mean forelimb_grip_mean 101571 average average normalized to bw	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:140	JaxKOMP-LAP	grip strength	(none)	forelimb and hindlimb grip strength (mean of trials) [g] all_paws_mean fore_and_hind_limb_grip_mean 101572 average average normalized to bw	KOMP	119	both	66-72wks	N=8	2021

Jaxpheno7:28	Jaxpheno7	observation (SHIRPA)	(none)	gait assessment within the arena (score 0-3) [score] gait 34928	inbred	6	m	10wks	N=8	2010

Jaxpheno7:30	Jaxpheno7	observation (SHIRPA)	(none)	body tone assessed by thumb and index finger compression while on horizontal wire-grid (score 0-2) [score] body_tone 34930	inbred	6	m	10wks	N=8	2010

Jaxpheno7:31	Jaxpheno7	observation (SHIRPA)	(none)	resistance to gentle finger-tip pressure of the hind paws during supine restraint (score 0-4) [score] limb_tone 34931	inbred	6	m	10wks	N=8	2010

Jaxpheno7:32	Jaxpheno7	observation (SHIRPA)	(none)	abdominal tone via palpation during supine restraint (score 0-2) [score] abdominal_tone 34932	inbred	6	m	10wks	N=8	2010

Jaxpheno7:59	Jaxpheno7	grip strength	(none)	grip strength, peak tension [g] grip 34959 trial1 trial2 trial3	inbred	6	m	10wks	N=8	2010

Jaxpheno7:62	Jaxpheno7	grip strength	(none)	grip strength mean peak tension over 3 trials [g] mean_grip 34962	inbred	6	m	10wks	N=8	2010

Jaxpheno7:63	Jaxpheno7	grip strength	(none)	grip strength maximum peak tension over 3 trials [g] max_grip 34963	inbred	6	m	10wks	N=8	2010

Jaxwest1:21	Jaxwest1	grip strength	(none)	grip strength mean peak tension over 5 trials [g] tension_mean 15121	inbred	7	both	9-12wks	N=8	2003

Jaxwest1:22	Jaxwest1	grip strength	(none)	grip strength maximum peak tension over 5 trials [g] tension_max 15122	inbred	7	both	9-12wks	N=8	2003

Karst1:6	Karst1	organ weights	(none)	muscle mass, as the sum of 2 Musculus longissimus (ml) + 2 Musculus quadriceps (mq) [g] msclemass 26006	QTL population		both	10wks	N=166	2011

Karst1:10	Karst1	organ weights	(none)	muscle mass, log-transformed [log(g)] logmsclemass 26010	QTL population		both	10wks	N=166	2011

Karst1:25	Karst1	metabolite quantification	(none)	glycogen content of the M. longissimus [mg/g] glyc 26025	QTL population		both	10wks	N=166	2011

Karst1:26	Karst1	metabolite quantification	(none)	glycogen content of the M. longissimus, log transformed [log(mg/g)] logglyc 26026	QTL population		both	10wks	N=166	2011

Karst1:27	Karst1	metabolite quantification	(none)	lactate content of the M. longissimus [mg/g] lac 26027	QTL population		both	10wks	N=166	2011

Karst1:28	Karst1	metabolite quantification	(none)	lactate content of the M. longissimus, log transformed [log(mg/g)] loglac 26028	QTL population		both	10wks	N=166	2011

Lake2:13	Lake2	observation (SHIRPA)	(none)	gait assessment within the arena (score 0-3) [score] gait 21713	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:15	Lake2	observation (SHIRPA)	(none)	body tone assessed by thumb and index finger compression while on horizontal wire-grid (score 0-2) [score] body_tone 21715	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:16	Lake2	observation (SHIRPA)	(none)	resistance to gentle finger-tip pressure of the hind paws during supine restraint (score 0-4) [score] limb_tone 21716	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:17	Lake2	observation (SHIRPA)	(none)	abdominal tone via palpation during supine restraint (score 0-2) [score] abdominal_tone 21717	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake3:13	Lake3	grip strength	(none)	grip strength mean peak tension over 3 trials [g] mean_grip 19013	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lake3:14	Lake3	grip strength	(none)	grip strength maximum peak tension over 3 trials [g] max_grip 19014	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lionikas1:11	Lionikas1	muscle weights	exercise	weight of tibialis anterior muscle [g] tibialis 48511 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:12	Lionikas1	muscle weights	exercise	weight of extensor digitorum longus muscle [g] extensor 48512 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:13	Lionikas1	muscle weights	exercise	weight of gastrocnemius muscle [g] gastrocnemius 48513 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:14	Lionikas1	muscle weights	exercise	weight of quadriceps femoris muscle [g] quadriceps 48514 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:15	Lionikas1	muscle weights	exercise	weight of soleus muscle [g] soleus 48515 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:16	Lionikas1	microscopy	exercise	cross-sectional area of type I fibers of soleus muscle [µm²] soleus_area1 48516 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:17	Lionikas1	microscopy	exercise	cross-sectional area of type IIa fibers of soleus muscle [µm²] soleus_area2A 48517 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:18	Lionikas1	microscopy	exercise	total number of fibers of soleus muscle [n] soleus_fibers 48518 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:19	Lionikas1	microscopy	exercise	number of type I fibers of soleus muscle [n] soleus_fibers1 48519 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:20	Lionikas1	microscopy	exercise	number of type IIa fibers of soleus muscle [n] soleus_fibers2A 48520 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:21	Lionikas1	microscopy	exercise	number of intermediate fibers of soleus muscle [n] soleus_intermediate 48521 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:22	Lionikas1	protein activity assessment	exercise	citrate synthase activity of gastrocnemius muscle [U/g] citrate_synthase 48522 control exercise	inbred	6	m	11-14wks	N=8	2012

Lionikas1:23	Lionikas1	protein activity assessment	exercise	β-hydroxyacyl-CoA dehydrogenase activity of gastrocnemius muscle [U/g] CoA 48523 control exercise	inbred	6	m	11-14wks	N=8	2012

Neuner1:50	Neuner1	grip strength	(none)	mean grip strength across 3 trials [g] grip_strength 65950 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Project1133:116	Project1133	grip strength	various diets 3	all-paws force - 3 trial average [Z-score] GS_APAW 116328 diet: AL 1D 2D 20 40	DO population		f	44 wks	N=130	2022

Project1133:121	Project1133	grip strength	various diets 3	forepaws force - 3 trial average [Z-score] GS_FORE 116333 AL 1D 2D 20 40	DO population		f	44 wks	N=130	2022

Project1170:13	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 1 [g] forepaw_T1 121669 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:15	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 2 [g] forepaw_T2 121671 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:17	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 3 [g] forepaw_T3 121673 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:19	Project1170	grip strength	fluoxetine	grip strength forepaws, average of all trials [g] forepaw_avg 121675 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:21	Project1170	grip strength	fluoxetine	grip strength forepaws, average of all trials adjusted for body weight [g] forepaw_avg_adj 121677 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:23	Project1170	grip strength	fluoxetine	grip strength all paws, trial 1 [g] all_paw_T1 121679 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:25	Project1170	grip strength	fluoxetine	grip strength all paws, trial 2 [g] all_paw_T2 121681 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:27	Project1170	grip strength	fluoxetine	grip strength all paws, trial 3 [g] all_paw_T3 121683 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:29	Project1170	grip strength	fluoxetine	grip strength all paws, average of all trials [g] all_paw_avg 121685 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:31	Project1170	grip strength	fluoxetine	grip strength all paws, average of all trials adjusted for body weight [g] all_paw_avg_adj 121687 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Schoonjans1:230	Schoonjans1	organ weights	high-fat diet	gastrocnemius muscle weight [g] gastroc_wt 112865 CD HFD	BXD w/par	35	m	29wks	N=5	2021

Schoonjans1:232	Schoonjans1	organ weights	high-fat diet	soleus muscle weight [g] soleus_wt 112867 CD HFD	BXD w/par	35	m	29wks	N=5	2021

Seburn2:1	Seburn2	grip strength	(none)	grip strength, peak tension over 3 trials [g] grip_strength 24801 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2008

Filter Table Results